INDIUM In 111 CAPROMAB PENDETIDE

Known as: 111-In Capromab Pendetide, indium (111In) capromab pendetide 
A radioimmunoconjugate consisting of the murine IgG1 kappa monoclonal antibody capromab (7E11-C5.3), conjugated to the linker-chelator glycyl-tyrosyl… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2016
02419982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A 62-year-old male with a history of radical prostatectomy for a Gleason 9 (4 + 5) pT3N0Mx prostate cancer presented with rising… (More)
Is this relevant?
2014
2014
PURPOSE We prospectively evaluated the amino acid analogue positron emission tomography radiotracer anti-3-[(18)F]FACBC compared… (More)
Is this relevant?
2011
2011
OBJECTIVE To evaluate alternative methods for radiochemical purity testing of indium (In)-111 capromab pendetide after the… (More)
Is this relevant?
2007
2007
PURPOSE To report biochemical disease-free survival (bDFS) after conformal brachytherapy with dose escalation to biological… (More)
Is this relevant?
2005
2005
UNLABELLED (111)In-Capromab pendetide imaging is indicated for postprostatectomy patients at risk for residual or recurrent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
OBJECTIVES No standard noninvasive diagnostic test reliably differentiates patients with organ-confined prostate cancer from… (More)
Is this relevant?
1998
1998
BACKGROUND Optimum therapy for prostate carcinoma patients requires accurate staging, but computed tomography (CT) and magnetic… (More)
Is this relevant?
1998
1998
To provide appropriate therapy for prostate cancer, accurate staging of the patient's disease is essential. Determination of… (More)
Is this relevant?
1998
1998
PURPOSE Standard diagnostic methods are limited for detecting distant metastases in patients with prostate cancer in whom the… (More)
Is this relevant?